Brief: Endo Announces Launch Of Argatroban Injection Through Premier's Prorx® Private-Label Program
17/04/2023 12:45
April 17 (Reuters) - Endo International PLC ENDPQ.PK :
* ENDO ANNOUNCES LAUNCH OF ARGATROBAN INJECTION THROUGH
PREMIER'S
PRORX® PRIVATE-LABEL PROGRAM
Source text for Eikon: ID:nCNWZrSfCa
Further company coverage: ENDPQ.PK
Recent news on Endo International
See all newsBrief: Endo International PLC Files For Offering Of Up To 31.1 Million Common Shares By The Selling Stockholders - SEC Filing
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes